Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin C for Prevention of Intravesical Recurrence in UTUC
NCT05979909Phase 1Not yet recruiting
- Sponsor
- McMaster University
- Start
- Sep 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of mitomycin c in upper tract urothelial carcinoma (UTUC) (2 arms), sponsored by McMaster University. Primary endpoints: Recruitment rate at 30 days, Randomization rate at 30 days and 1 more. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
mitomycin c
03
Conditions
upper tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT05979909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05979909.